Biotech Startup D3Bio Completes $200 Million Series A Round

This Data Is Locked!

This area is available only to Subscribers.

Chinese biotech firm D3Bio has recently announced the completion of a US$200 million Series A financing. This round of financing is co-invested by Boyu Capital,... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?